Current insights in sepsis: from pathogenesis to new treatment targets.
about
A Review of GM-CSF Therapy in SepsisHost innate immune responses to sepsisGenomic responses in mouse models poorly mimic human inflammatory diseasesEpinephrine enhances the response of macrophages under LPS stimulation.Effect of statin use on outcomes of adults with candidemia.Cardiac fibroblasts contribute to myocardial dysfunction in mice with sepsis: the role of NLRP3 inflammasome activationComparison of Gene Expression by Sheep and Human Blood Stimulated with the TLR4 Agonists Lipopolysaccharide and Monophosphoryl Lipid A.Blood-Brain Barrier Deterioration and Hippocampal Gene Expression in Polymicrobial Sepsis: An Evaluation of Endothelial MyD88 and the Vagus NerveHigh-dose ascorbate with low-dose amphotericin B attenuates severity of disease in a model of the reappearance of candidemia during sepsis in the mouse.Triggering Receptor Expressed on Myeloid Cells (TREM)-2 Impairs Host Defense in Experimental MelioidosisNeutrophil extracellular traps in the host defense against sepsis induced by Burkholderia pseudomallei (melioidosis)Lipopolysaccharide clearance, bacterial clearance, and systemic inflammatory responses are regulated by cell type-specific functions of TLR4 during sepsis.Stat2 loss leads to cytokine-independent, cell-mediated lethality in LPS-induced sepsis.Persistent inflammation and immunosuppression: a common syndrome and new horizon for surgical intensive careSepsis modeling in mice: ligation length is a major severity factor in cecal ligation and punctureTLR9 deficiency promotes CD73 expression in T cells and diabetes protection in nonobese diabetic mice.Prolonged systemic inflammation persistently modifies synaptic plasticity in the hippocampus: modulation by the stress hormones.Heterogeneity among septic shock patients in a set of immunoregulatory markers.Baicalin Protects Mice from Lethal Infection by Enterohemorrhagic Escherichia coli.Of mice and men: what rodent models don't tell us.Applications of nanotechnology for immunology.miR-15a/16 regulates macrophage phagocytosis after bacterial infection.Maximizing the potency of an anti-TLR4 monoclonal antibody by exploiting proximity to Fcγ receptors.Mitochondria and the NLRP3 inflammasome: physiological and pathological relevance.Impaired cell functions of hepatocytes incubated with plasma of septic patients.A synthetic lipid A mimetic modulates human TLR4 activityFebrile response induced by cecal ligation and puncture (CLP) in rats: involvement of prostaglandin E2 and cytokines.[Epigenetic regulation in sepsis : current state of knowledge].Alpha-1 acid glycoprotein reduces hepatic leukocyte recruitment in murine models of either early endotoxemia or early sepsis.Cellular Therapy for Sepsis: A New Hope?Nucleic acid scavenging microfiber mesh inhibits trauma-induced inflammation and thrombosis.Early immune anergy towards recall antigens and mitogens in patients at onset of septic shock.Impaired Cell Viability and Functionality of Hepatocytes After Incubation With Septic Plasma—Results of a Second Prospective Biosensor Study.
P2860
Q26774775-63DAC449-FD32-4FAA-9651-28B242ADC057Q26864635-F9E0F372-E88E-4DCF-9BA1-C4FA8D255340Q29547718-A6F7E0DF-BCA9-40C5-9287-FDB40BAD6C73Q34162127-85984955-A87F-44F5-8A90-6E12B0C4C43DQ35025431-0A96586B-B0AF-4325-B364-34B0FE099CD7Q35250425-D14D20DC-7CB2-4FA5-84F6-088B637622E3Q35862009-46FCAB39-A790-409C-9F92-9F7C62AF5CEAQ35899076-954D1CC5-FCCD-4629-86B9-7915F683DCC6Q35917505-FEBB4FF7-C62C-440B-A5C1-006E54E0BC6AQ36037861-015E4FE5-CE20-408B-8946-BFA0AAEE7669Q36369202-13E2B8A3-508A-4681-B65D-017DEBB28C89Q36818068-3F590D24-1749-41FD-8E21-815C6A9E7D56Q36884311-47D9DBA3-219A-41AF-8C93-BA647B8D233BQ36995660-C5871637-AAC7-4363-A002-35E6FA0C2867Q37104389-37E9906B-8181-4E04-98FC-E6421F486504Q37210998-632E9FA2-87AC-412E-A772-B924D32B38B5Q37362496-D1AF11ED-FF92-4421-BFD1-EBC181BD1016Q37585971-8E2A3098-0342-4A6C-84DD-2B53B55BC2F4Q37689464-C80EC77A-E09F-444C-9B4A-5644320F1A0FQ37729650-B2785B2C-C019-4D6C-A38B-E38698044243Q38123937-8227D15B-7152-4A4C-AA64-EE1B5210A85AQ38433642-4B5ABAAB-1C26-4908-A65D-374C3AA8C576Q38931186-D86AD42E-1DC8-477E-AEB1-7A19DF42E650Q38947693-3C688E76-65FD-409F-9D08-290066835392Q39389129-57C220CC-2755-4F40-B7FD-DF1D723F7E84Q39433199-221A542B-4EAB-40CF-82D6-9D6BCC3563F7Q40301326-C643B25A-123E-4D12-B133-5B1D8DC72AA6Q41620454-5CBB13BA-C129-4FAD-9CE3-2ECFB7196335Q43408139-334FFFFA-CFE6-455A-A1EC-65DC5337B100Q47597125-EB6444C2-A631-4AA9-8E24-89F367400F75Q48881688-582C3D0D-83EC-4CB7-A543-1686585B4C34Q49259114-A53BD85A-82E7-4E3B-A91E-4D84A42BAF0FQ55472665-949B6157-6BB2-415C-8133-E296187C27FD
P2860
Current insights in sepsis: from pathogenesis to new treatment targets.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Current insights in sepsis: from pathogenesis to new treatment targets.
@en
Current insights in sepsis: from pathogenesis to new treatment targets.
@nl
type
label
Current insights in sepsis: from pathogenesis to new treatment targets.
@en
Current insights in sepsis: from pathogenesis to new treatment targets.
@nl
prefLabel
Current insights in sepsis: from pathogenesis to new treatment targets.
@en
Current insights in sepsis: from pathogenesis to new treatment targets.
@nl
P1476
Current insights in sepsis: from pathogenesis to new treatment targets.
@en
P2093
W Joost Wiersinga
P304
P356
10.1097/MCC.0B013E32834A4AEB
P577
2011-10-01T00:00:00Z